Roxithromycin is a semisynthetic macrolide antibiotic and is sparingly soluble in aqueous solution ( 0.019 mg/mL).</br>Macrolide antibiotics inhibit bacterial growth by targeting the 50S ribosomal subunit preventing peptide bond formation and translocation during protein synthesis. Resistance to roxithromycin is commonly attributed to mutations in 50S rRNA preventing roxithromycin binding allowing the cell to synthesize proteins free of error.
| Catalog Number | A000411 |
| CAS Number | 80214-83-1 |
| Synonyms | Roxl-150 |
| Molecular Formula | C₄₁H₇₆N₂O₁₅ |
| Purity | 95% |
| Storage | 3 years -20C powder |
| InChI | InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31-/t22-,23 |
| InChIKey | RXZBMPWDPOLZGW-HEWSMUCTSA-N |
| SMILES | CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O |
| Reference | <p>Lovmar, Martin, and Tanel Tenson. /The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome./<em>Journal of Molecular Microbiology</em> 330.5 (2003): 1005-014.</p></span></p> |
